In its Global report on hypertension 2025, during the 80th United Nations General Assembly, the WHO shared the example of India for its successful pricing approaches for essential hypertension medicines. Launched in 2018-2019, the government’s India Hypertension Control Initiative (IHCI) ensured a reliable supply of free, quality-assured generic antihypertensive medicines in public sector clinics. The report stated that before these reforms were initiated, hypertension control rates in India were low — only about 14 per cent of hypertensive adults achieved blood pressure control. The analysis of data from 195 countries and territories shows that 99 of them have national hypertension control rates below 20 per cent. Only 28 per cent of low-income countries report that all WHO-recommended hypertension medicines are generally available in pharmacies or primary care facilities.